Beyond Cholesterol: Getting the Full Lipid Profile

The Standard Lipid Panel and Its Limitations

A routine lipid panel reports four values: total cholesterol, LDL-C, HDL-C, and triglycerides. Physicians have used this panel for decades to assess cardiovascular risk, but cardiovascular research over the past 20 years has substantially revised what these numbers actually predict.

The fundamental problem: total cholesterol and LDL-C measure the mass of cholesterol carried in lipoproteins — not the number of atherogenic particles themselves. Two people can have identical LDL-C values while having dramatically different numbers of LDL particles, and it is the particle number — not the cholesterol mass — that determines arterial plaque deposition.

What Your Lipid Panel Numbers Mean

Total Cholesterol

Has limited predictive value in isolation. High total cholesterol driven by elevated HDL is very different from the same total driven by elevated LDL. Treating this number as the primary target is a significant oversimplification.

LDL-C (Low-Density Lipoprotein Cholesterol)

Estimates the amount of cholesterol carried in LDL particles. Useful as a screening tool but limited by the particle size problem: small, dense LDL particles carry less cholesterol per particle but are far more atherogenic than large, buoyant particles — yet produce lower LDL-C readings.

HDL-C (High-Density Lipoprotein Cholesterol)

Historically called "good cholesterol." Low HDL (below 40 mg/dL in men, below 50 mg/dL in women) is associated with elevated cardiovascular risk. However, genetic studies have shown that artificially raising HDL through drugs does not reduce cardiovascular events — suggesting HDL-C is more of a risk marker than a causal driver.

Triglycerides/HDL ratio: More useful than either number alone. A ratio above 3.0 indicates an LDL particle pattern dominated by small, dense particles — a highly atherogenic state independent of LDL-C levels.

Triglycerides

Elevated triglycerides (above 150 mg/dL fasting) reflect impaired fat clearance, usually driven by excess refined carbohydrates, alcohol, or insulin resistance. Optimal levels are below 80 mg/dL.

The Superior Metrics

ApoB (Apolipoprotein B)

Every atherogenic lipoprotein particle — LDL, VLDL, IDL, Lp(a) — carries exactly one ApoB molecule. Measuring ApoB directly counts the number of atherogenic particles rather than estimating cholesterol mass. Multiple meta-analyses confirm ApoB is a more accurate predictor of cardiovascular events than LDL-C.

Optimal ApoB: Below 80 mg/dL (ideally below 60 mg/dL for high-risk individuals).

Lp(a) — Lipoprotein(a)

An LDL-like particle with an additional adhesive protein (apolipoprotein(a)) that makes it particularly prone to arterial wall penetration. Lp(a) is 80–90% genetically determined — unaffected by diet or exercise. Testing once in your lifetime is sufficient to establish your inherited baseline. Elevated Lp(a) (above 30 mg/dL or 75 nmol/L) affects approximately 20% of the population and doubles or triples cardiovascular risk independent of other factors.

Building Your Complete Cardiovascular Picture

For a genuinely comprehensive assessment, request:

1. Standard lipid panel
2. ApoB
3. Lp(a) — once in your lifetime
4. hs-CRP (inflammatory context)
5. Fasting insulin (metabolic context)

This five-test panel costs less than a gym membership for a month and provides a far more complete cardiovascular risk picture than cholesterol alone.